mart-1-antigen and Lipoma

The renal angiomyolipoma (AML) is a benign tumor characteristically composed of fat, smooth muscle tissue, and vessels. We collected AMLs from our nephrectomy database, reclassified them according to their histological appearance, recorded the demographic, clinical, and pathological parameters, and compared them with oncocytoma (RO) and renal cell carcinoma (RCC). Immunohistochemistry was ordered in 41 cases. In 2224 nephrectomies, we found 52 AMLs with a 53 mm median size. The mean age was 52.76. Forty-eight tumors were sporadic, while four were hereditary. The revision resulted in 31 classic, 13 leiomyoma-like, five lipoma-like, two epithelioid, and one AML with epithelial cysts. SMA was diffusely positive, except for the epithelioid type, while MelanA harbored stronger expression than HMB45. AML was more frequent in females and appeared ten and 7 years earlier than RO and RCC, respectively. The follow-up time was 7.42 years, and neither tumor-related death nor relapse occurred. AML is rare in nephrectomies and develops primarily in females in their 50s with an average size of 50-60 mm at the surgery. The histological appearance in order of frequency is classic, leiomyoma-like, lipoma-like, epithelioid, and cystic. The MelanA, HMB45, and SMA immunohistochemistry can support the light-microscopic findings.

Topics: Angiomyolipoma; Antibodies, Monoclonal; Carcinoma, Renal Cell; Female; Hamartoma; Humans; Kidney; Kidney Neoplasms; Leiomyoma; Lipoma; MART-1 Antigen; Middle Aged

Topics: Adipose Tissue; Adolescent; Antigens, Neoplasm; Biomarkers, Tumor; Female; Fibroma; Humans; Lipoma; MART-1 Antigen; Neoplasm Proteins; Pigmentation; S100 Proteins; Soft Tissue Neoplasms; Treatment Outcome